Verified Supplement Data

Best Boswellia Supplements 2026: Cost per Effective Dose

A day of boswellia costs $0.09 to $1.97 at brand prices; our pick costs $0.28, the least of the extracts knee trials tested. The cheaper ones are not those extracts.

By Erin Rose Updated October 19, 2026 How we score

What a day of boswellia costs, cheapest first

The 8 boswellia supplements we link, at each label’s directions and each brand’s own price, checked October 19, 2026. Amazon’s price can differ.
ProductPer day
Carlyle Boswellia 375 mg blend, 1 capsule; $21.39 for 250 daysCheck price $0.09
Double Wood Boswellia 1,000 mg of a 65% extract, 2 capsules; $19.95 for 120 daysCheck price $0.17
AMANDEAN Boswellia 500 mg 500 mg of a 65% extract, 1 capsule; $21.95 for 120 daysCheck price $0.18
Life Extension Boswellia (AprèsFlex) 100 mg AprèsFlex (20% AKBA), 1 capsule; a trial extract; $16.50 for 60 daysCheck price $0.28
Pure Encapsulations Boswellia AKBA 100 mg 5-LOXIN (30% AKBA), 1 capsule; a trial extract; $34.00 for 60 daysCheck price $0.57
Terry Naturally BosMed 500 500 mg BOS-10 (10% AKBA), 1 softgel; $88.95 for 120 daysCheck price $0.74
Swanson Boswellia (5-LOXIN) 125 mg 5-LOXIN (30% AKBA) a capsule, 2 a day; a trial extract; $24.79 for 30 daysCheck price $0.83
Thorne Boswellia Phytosome 350 mg phytosome a capsule, 2 a day; on NSF/ANSI 173; $59.00 for 30 daysCheck price $1.97

Ranked on dose, testing and labels as well as cost in the best boswellia supplements.

Why the cheapest is not the best buy

Knee trials tested named extracts, 5-LOXIN and AprèsFlex, at 100 mg a day or more (Sengupta 2008; Vishal 2011). The lower-cost products here use other extracts or a blend, so a cheaper serving buys milligrams of a different thing. See what the research found.

Take the label serving. If you take any medicine, or are pregnant or breastfeeding, ask your doctor first.

Sources

  1. Prices: each brand’s own regular price, checked October 19, 2026 (AMANDEAN’s on October 30, 2026).
  2. Extract and milligrams: each product’s label.
  3. Testing list: NSF/ANSI 173.
  4. Sengupta K, et al. “A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.” Arthritis Res Ther. 2008. PubMed 18667054
  5. Vishal AA, et al. “A double blind, randomized, placebo controlled clinical study evaluates the early efficacy of aflapin in subjects with osteoarthritis of knee.” Int J Med Sci. 2011. PubMed 22022214